Glenmark Life Sciences Limited
ListedMainboardHealthcare & Pharmaceuticals · NSE / BSE
Incorporated in 2011, Glenmark Life Sciences is a leading manufacturer of active pharmaceutical ingredients (APIs), developing and supplying high-quality products used in treatments for cardiovascular, central nervous system, pain management, diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas. The company serves customers in India and exports its products to several international markets including Europe, North America, Latin America, and Japan. It operates four manufacturing facilities located at Ankleshwar and Dahej in Gujarat, and Mohol and Kurkumbh in Maharashtra, with a total annual installed capacity of 725.8 KL as of December 31, 2020.
Price Band
₹695 – ₹720
Issue Size
₹1514 Cr
Lot Size
20 shares
GMP
₹82
+11.4%
Est. Listing
₹802
at current GMP
Subscribed
—
Open
27 Jul 2021
Close
29 Jul 2021
Allotment
3 Aug 2021
Refund
4 Aug 2021
Demat Credit
5 Aug 2021
Listing
6 Aug 2021
Last updated 12 days ago
Key Highlights
- •Leading player in the Healthcare & Pharmaceuticals segment
- •Price band established at ₹695 - ₹720 per equity share
- •Minimum bid lot is 20 shares
- •Estimated listing target of ₹802 based on current grey market activity